Julie L. Forman
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 176 publications
BASTA trial: protocol for a randomised, double-blind, placebo-controlled, crossover trial investigating the effects of atorvastatin on bile acid diarrhoea.
Journal: BMJ open
Published: July 28, 2026
Circulating levels of PYY are increased in individuals with bile acid diarrhoea.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 25, 2026
The effect of empagliflozin on inflammation in patients with overweight or obesity and risk of heart failure: a substudy from the Empire Prevent Metabolic trial.
Journal: Cardiovascular diabetology
Published: February 24, 2026
Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trial.
Journal: The lancet. Diabetes & endocrinology
Published: December 10, 2025
Randomized controlled single-center clinical trial of high-intensity interval training in patients with systemic lupus erythematosus.
Journal: Journal of autoimmunity
Published: November 25, 2025
The VIA Family 2.0 study: a randomized clinical trial evaluating a family-based intervention for children born to parents with mental illnesses-study protocol.
Journal: Trials
Published: October 26, 2025
Risk of minor congenital heart defect in infants conceived via assisted reproductive technology: cohort study from the Copenhagen Baby Heart Study.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: October 24, 2025
Empagliflozin and functional aerobic capacity in individuals with increased risk of heart failure: The Empire Prevent Cardiac trial.
Journal: American heart journal
Published: October 09, 2025
The Effect of Empagliflozin on Left Ventricular Mass and Volumes in Older Adult Individuals With Overweight and High Risk of Heart Failure: The Empire Prevent Cardiac Trial.
Journal: Journal of cardiac failure
Published: September 26, 2025
Selenium supplementation in individuals with newly diagnosed Graves' hyperthyroidism: a double-blind, multi-centre RCT.
Journal: European thyroid journal
Published: September 04, 2025
Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trial.
Journal: EClinicalMedicine
Published: September 01, 2025
Last Updated: 09/26/2026